A logo of Tencent is seen at its booth at the 2020 China International Fair for Trade in Services (CIFTIS) in Beijing, on Sept 4, 2020. (Photo: Agencies)

Tencent Holdings Ltd has unveiled two medical products in a row that use technology to accelerate medical artificial intelligence and enhance the delivery of healthcare services.

In a medical trade show in Shanghai, the company announced Tencent AIMIS Medical Image Cloud, which stands to enable patients to manage their X-ray, CT and MRI images and facilitate the safe and secure sharing of patient medical data.

Also making its debut is its namesake open lab, which is positioned to share Tencent's medical AI capabilities with third-party partners from research institutions to universities and innovative enterprises to incubate AI medical applications.

"The medical industry is ripe for technological innovation that can improve outcomes for patients and their doctors," said Wang Shaojun, vice-president of Tencent Healthcare. "We are building a comprehensive medical AI portfolio including Tencent AIMIS, the Guide and Assistant Diagnosis System, and the Tumor Assistant Diagnosis System, which have proven the feasibility of combining AI with medical treatments."

The newly launched Image Cloud circumvents the trouble of conducting repeated examinations. Patients can also manage their personal data, as well as authorize sharing and mutual recognition between hospitals all in one place.

Tencent AIMIS Open Lab provides clinicians and technology enterprises with comprehensive services such as data desensitization, access, annotation, the ability to model training, and testing. They can also develop medical AI applications more efficiently, which helps to develop the industry and bring benefits to more patients.